Latest PERCEPTIVE ADVISORS LLC Stock Portfolio
PERCEPTIVE ADVISORS LLC Performance:
2024 Q4: -3.96%YTD: 7.89%2023: 18.41%
Performance for 2024 Q4 is -3.96%, and YTD is 7.89%, and 2023 is 18.41%.
About PERCEPTIVE ADVISORS LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, PERCEPTIVE ADVISORS LLC reported an equity portfolio of $3.6 Billions as of 31 Dec, 2024.
The top stock holdings of PERCEPTIVE ADVISORS LLC are VRNA, ACLX, FOLD. The fund has invested 8.2% of it's portfolio in VERONA PHARMA PLC and 7.3% of portfolio in ARCELLX INC.
The fund managers got completely rid off BIOHAVEN LTD, INSTIL BIO INC (TIL) and LIVANOVA PLC (LIVN) stocks. They significantly reduced their stock positions in APPLIED THERAPEUTICS INC (APLT), TARSUS PHARMACEUTICALS INC (TARS) and CRINETICS PHARMACEUTICALS IN (CRNX). PERCEPTIVE ADVISORS LLC opened new stock positions in JANUX THERAPEUTICS INC (JANX), INHIBIKASE THERAPEUTICS INC (IKT) and PENUMBRA INC (PEN). The fund showed a lot of confidence in some stocks as they added substantially to AMYLYX PHARMACEUTICALS INC (AMLX), IRHYTHM TECHNOLOGIES INC (IRTC) and INSULET CORP (PODD).
The top stock holdings of PERCEPTIVE ADVISORS LLC are VRNA, ACLX, FOLD. The fund has invested 8.2% of it's portfolio in VERONA PHARMA PLC and 7.3% of portfolio in ARCELLX INC.
The fund managers got completely rid off BIOHAVEN LTD, INSTIL BIO INC (TIL) and LIVANOVA PLC (LIVN) stocks. They significantly reduced their stock positions in APPLIED THERAPEUTICS INC (APLT), TARSUS PHARMACEUTICALS INC (TARS) and CRINETICS PHARMACEUTICALS IN (CRNX). PERCEPTIVE ADVISORS LLC opened new stock positions in JANUX THERAPEUTICS INC (JANX), INHIBIKASE THERAPEUTICS INC (IKT) and PENUMBRA INC (PEN). The fund showed a lot of confidence in some stocks as they added substantially to AMYLYX PHARMACEUTICALS INC (AMLX), IRHYTHM TECHNOLOGIES INC (IRTC) and INSULET CORP (PODD).
PERCEPTIVE ADVISORS LLC Annual Return Estimates Vs S&P 500
Our best estimate is that PERCEPTIVE ADVISORS LLC made a return of -3.96% in the last quarter. In trailing 12 months, it's portfolio return was 7.89%.
New Buys
| Ticker | $ Bought |
|---|---|
| janux therapeutics inc | 43,790,100 |
| inhibikase therapeutics inc | 19,256,200 |
| penumbra inc | 17,416,300 |
| septerna inc | 17,175,000 |
| bright minds biosciences inc | 14,539,400 |
| anteris technologies global | 11,941,200 |
| edwards lifesciences corp | 10,734,400 |
| rapt therapeutics inc | 9,290,400 |
New stocks bought by PERCEPTIVE ADVISORS LLC
Additions
| Ticker | % Inc. |
|---|---|
| amylyx pharmaceuticals inc | 218 |
| irhythm technologies inc | 188 |
| insulet corp | 63.26 |
| eyepoint pharmaceuticals inc | 48.2 |
| mereo biopharma group plc | 33.07 |
| immatics n.v | 16.04 |
| edgewise therapeutics inc | 15.24 |
| praxis precision medicines i | 14.23 |
Additions to existing portfolio by PERCEPTIVE ADVISORS LLC
Reductions
| Ticker | % Reduced |
|---|---|
| applied therapeutics inc | -89.26 |
| tarsus pharmaceuticals inc | -85.6 |
| crinetics pharmaceuticals in | -74.54 |
| ocular therapeutix inc | -67.56 |
| pyxis oncology inc | -62.93 |
| rocket pharmaceuticals inc | -59.37 |
| rapport therapeutics inc | -58.36 |
| verrica pharmaceuticals inc | -54.22 |
PERCEPTIVE ADVISORS LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| x4 pharmaceuticals inc | -2,372,970 |
| allogene therapeutics inc | -7,630,000 |
| biohaven ltd | -74,217,000 |
| arcutis biotherapeutics inc | -12,634,000 |
| roivant sciences ltd | -9,782,980 |
| absci corporation | -2,674,000 |
| envveno medical corporation | -2,332,900 |
| springworks therapeutics inc | -22,180,100 |
PERCEPTIVE ADVISORS LLC got rid off the above stocks
Sector Distribution
PERCEPTIVE ADVISORS LLC has about 87.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 87.5 |
| Others | 12.5 |
Market Cap. Distribution
PERCEPTIVE ADVISORS LLC has about 4.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 55.1 |
| SMALL-CAP | 24.6 |
| UNALLOCATED | 12.6 |
| LARGE-CAP | 4.1 |
| MICRO-CAP | 2.8 |
Stocks belong to which Index?
About 66.6% of the stocks held by PERCEPTIVE ADVISORS LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 63.7 |
| Others | 33.4 |
| S&P 500 | 2.9 |
PERCEPTIVE ADVISORS LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC has 97 stocks in it's portfolio. About 50.3% of the portfolio is in top 10 stocks. NUVL proved to be the most loss making stock for the portfolio. VRNA was the most profitable stock for PERCEPTIVE ADVISORS LLC last quarter.
Last Reported on: 14 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACLX | arcellx inc | 7.35 | 3,478,890 | 266,796,000 | reduced | -10.54 | ||
| ADMA | adma biologics inc | 0.42 | 890,280 | 15,268,300 | reduced | -16.03 | ||
| AGLE | spyre therapeutics inc | 1.65 | 2,574,720 | 59,939,600 | reduced | -10.37 | ||
| AKRO | akero therapeutics inc | 0.91 | 1,185,590 | 32,983,200 | reduced | -30.86 | ||
| ALDX | aldeyra therapeutics inc | 1.28 | 9,275,850 | 46,286,500 | unchanged | 0.00 | ||
| ALLO | allogene therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMLX | amylyx pharmaceuticals inc | 0.71 | 6,774,350 | 25,607,000 | added | 218 | ||
| AORT | artivion inc | 2.20 | 2,793,700 | 79,872,000 | unchanged | 0.00 | ||
| APLT | applied therapeutics inc | 0.02 | 860,000 | 736,332 | reduced | -89.26 | ||
| APYX | apyx medical corporation | 0.01 | 150,000 | 237,000 | new | |||
| ARQT | arcutis biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARVN | arvinas inc | 0.39 | 740,749 | 14,200,200 | reduced | -27.93 | ||
| ATHA | athira pharma inc | 0.09 | 5,402,960 | 3,169,920 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 1.60 | 6,485,420 | 57,979,700 | unchanged | 0.00 | ||
| AXSM | axsome therapeutics inc | 1.55 | 664,074 | 56,187,300 | reduced | -15.17 | ||
| BCYC | bicycle therapeutics plc | 0.08 | 197,108 | 2,759,510 | reduced | -23.00 | ||
| BDSX | biodesix inc | 0.09 | 2,173,880 | 3,326,040 | unchanged | 0.00 | ||
| CELC | celcuity inc | 0.85 | 2,362,280 | 30,922,200 | unchanged | 0.00 | ||
| CMAX | caremax inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||